In Brief: Fuisz Technologies
This article was originally published in The Tan Sheet
Executive Summary
Fuisz Technologies: Receives second milestone payment from SmithKline Beecham, marking "successful completion of consumer research and stability tests in the development of an EZ Chew version of a major, currently marketed SmithKline Beecham OTC product," the company announces July 19. Fuisz announced an initial payment in early July ("The Tan Sheet" July 2, In Brief). The companies have not revealed the product under development, but SmithKline has published for opposition the trademarks Quickchew Tums, Fastchew Tums and Tums Melts ("The Tan Sheet" July 29, p. 26). Fuisz also has a new agreement with General Mills "regarding the use of certain of Fuisz's proprietary food product technologies in certain food product applications," the company reports...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning